<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
Longevity Leaders World Congress

21-22 April 2020
London, UK
 

Ageing Science Agenda

Day 1 - Tuesday 21st April

THE LONGEVITY OPPORTUNITY

08:00

Registration opens
08:35

Chairman’s opening remarks
08:45

Keynote panel: Facilitating “ageing well” to access the longevity dividend
09:30

Insurer presentation
09:45

Investor presentation
10:00

Keynote panel: Ageing science, health span and the potential to dramatically change how we treat disease
10:45

Morning break

Regulation

11:30

Investor presentation
12:00

Investor presentation
12:30

Investor presentation
13:00

Lunch
Poster session
Biotech CEO Lunch Forum
The CEO Forum provides a unique, powerful and valuable space for the candid sharing of experience between the sector’s most senior executives so that they can leave with new ideas that will drive their businesses and the sector forward. It is an invitation only, exclusive round table forum where all participants are active discussants and have an equal voice. Limited to a maximum of 30 CxOs to ensure conversation is meaningful, it follows a strict Chatham House Rule policy and includes case study peer review and a general discussion focused on brainstorming solutions to the collective challenges of CxOs in the sector.

Clinical Design

14:30

Basket trials applied to health span
14:55

Designing a clinical trial for ageing
15:20

Panel: Considering ageing cohorts in clinical trial recruitment, retention and monitoring
16:00

Afternoon break

Clinical Progress

16:30

Modulating mTORC1 signalling to normalise cellular metabolic response
17:00

Activating key resilience pathways that counteract the effects of multiple biological and environmental stresses
17:30

Panel: Expanding age-related disease indications using a systems biology approach
18:15

Drinks reception
DOWNLOAD BROCHURE

Day 2 - Wednesday 22nd April

08:00

Registration opens

Funding & Investment

09:00

Advocacy panel: Bringing attention and investment to health span
09:45

Investor panel: Challenges and opportunities investing in ageing
10:30

Morning break

Insights into primordial ageing mechanisms

11:15

The next frontier: addressing gaps in our knowledge
11:45

Peptoid analogues of antimicrobial peptides for treatment against Age-Related Immuno Dementia
12:15

Age-related changes in the repair of DNA double-strand breaks
12:45

Pathways regulating growth and metabolism and their role in age-related disease
13:15

Lunch

Biomarker discovery

14:30

Developing genetic biomarkers for cell senescence
15:00

Methods and applications surrounding epigenetic data to study age-related diseases
15:30

Targeting the pathogenic cause of neurodegeneration
16:00

Proteomics of ageing and neurodegeneration
16:30

Afternoon break

Fuelling a movement

17:00

Panel: Selling ageing to investors, corporates and consumers
17:45

Close of congress
DOWNLOAD BROCHURE